Aidspan, an independent watchdog of the Global Fund, on Wednesday published Issue 192 of its “Global Fund Observer.” The issue features an article examining new reports released by the Office of the Inspector General on three audits and four diagnostic reviews; an article highlighting two reports on the impact of the cancellation of Round 11 by the Global Fund; and an article discussing the reaction to Spain’s Global Fund contribution, among others (8/15).
This post in the Center for Global Health Policy’s “Science Speaks” blog examines the use of stavudine, “also known as d4T, an antiretroviral treatment that was dropped in wealthy countries years ago and that the World Health Organization has recommended stop being included in treatment programs,” to treat HIV in Malawi. “[W]hile children and pregnant or breastfeeding women, as well as tuberculosis patients have access to less toxic treatments, stavudine continues to be the first treatment supplied to most Malawi patients under the terms of the country’s grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria,” the blog writes, adding, “In a letter [.pdf] to Global Fund General Manager Gabriel Jaramillo and [U.S. Global AIDS Coordinator Ambassador] Eric Goosby, the Centre for Development of People (CEDEP), Health GAP (Global Access Project), and the Malawi Network of People Living with HIV/AIDS (MANET+) are asking the Global Fund to find a way to switch to first line treatment in Malawi that is acceptable to patients and World Health Organization standards” (8/15).
In this post in Huffington Post’s “Impact” blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines “the success of U.S. efforts to promote better global health through support for [PEPFAR] and the Global Fund to Fight AIDS, Tuberculosis and Malaria.” She highlights U.S. Secretary of State Hillary Clinton’s recent trip to Africa, writing that Clinton’s “encouraging words” at the Reach Out Mbuya health center in Uganda reinforced U.S. commitment to an AIDS-free generation. She notes both PEPFAR and the Global Fund have supported the center and adds that “through hundreds of similar local programs all over the world, the Global Fund provides treatment to 3.6 million people who are HIV-positive.”
“Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV,” IRIN reports. The news service notes that “illegal use of pharmaceutical substances, mostly buprenorphine, is on the rise” in the country. “Buprenorphine was intended to be used to wean injecting drug users, also known as people who inject drugs (PWID), from narcotics like heroin, but has itself become a substance of addiction, with users injecting a liquid form of it,” the news service notes, adding, “Methadone, a pain reliever, suppresses withdrawal symptoms and blocks craving.”
The U.S. Government Accountability Office (GAO) recently released two reports on issues related to global health. In “Ensuring Drug Quality in Global Health Programs,” the agency writes, “Concerns have been raised about the potential for substandard drugs to enter the supply chains of global health programs,” and notes that it concluded, “U.S.-funded global health programs have put regulatory and policy requirements in place to help prevent procurement of substandard drugs” (8/1). In another report looking at the WHO, titled “Reform Agenda Developed, but U.S. Actions to Monitor Progress Could be Enhanced,” GAO found, “The United States has provided input into WHO’s reform agenda, particularly in the areas of transparency and accountability, but the Department of State’s (State) tool for assessing progress in the area of management reform could be enhanced” (7/23).
Some members of Congress “are advocating deep cuts to funding for domestic programs such as [the Ryan White CARE Act] and international programs such as the Global Fund [to Fight AIDS, Tuberculosis and Malaria] and PEPFAR,” but “[w]hat these critics fail to realize is that though we have won a multitude of battles, we are still losing the war in many communities,” Rep. Michael Honda (D-Calif.) writes in a U.S. News & World Report opinion piece. “We must continue to find innovative, targeted solutions in the fight against this dreaded disease,” he continues, adding, “There are many of us in Congress who recognize this important fact, chief among those are my dear friend Rep. Barbara Lee [D-Calif.], whose upcoming ‘Ending the HIV/AIDS Epidemic Act of 2012’ targets at-risk populations both domestically and internationally.” Honda concludes, “From legislative action on the federal level to grassroots efforts in state communities, we need to make targeting these communities a top priority in order to move forward. This requires advocacy, this requires commitment, and most importantly, it requires more investment” (7/27).
Sen. Dick Lugar (R-Ind.) “announced Thursday that he would release his hold on the $250 million meant to go from the President’s Emergency Plan for AIDS Relief (PEPFAR) to the Global Fund to Fight AIDS, Tuberculosis and Malaria,” saying “he was swayed by conversations at the International AIDS Conference [AIDS 2012] under way in Washington, D.C.,” The Hill’s “Healthwatch” blog reports (Viebeck, 7/26). “My biggest concern about the transfer was the shortfalls this may cause in our bilateral efforts to combat HIV/AIDS,” Lugar said, according to a press release from the senator’s office (7/26). “‘The leaders I met with this week expressed their confidence that the money is a worthy investment, and, given their strong leadership, I have decided to lift my hold on the transfer funds,’ Lugar, the ranking Republican on the Foreign Relations Committee, said in a written statement,” CQ HealthBeat notes (Ethridge/Cadei, 7/26). In related news, the U.S. Senate on Thursday introduced and passed a resolution “expressing support for the XIX International AIDS Conference and the sense of the Senate that continued commitment by the United States to HIV/AIDS research, prevention, and treatment programs is crucial to protecting global health,” the New York Times’ “Inside Congress” reports (7/26).
The Center for Global Development’s “Global Health Policy” blog reports on a session at the XIX International AIDS Conference (AIDS 2012) examining “how PEPFAR and the Global Fund [to Fight AIDS, Tuberculosis and Malaria] could collaborate more strategically to maximize impact.” According to the blog, the session “featured insight from high-level PEPFAR and Global Fund officials, focused on the progress made and challenges faced as the two funding agencies try to increase collaboration,” and was “followed by three country-level perspectives from Haiti, Tanzania and Malawi” (Duran, 7/26).
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship “focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS,” the Center for Global Health Policy’s “Science Speaks” blog reports (Mazzotta, 7/25). During the session, Rubio “expressed strong support for foreign aid, especially funding to combat HIV/AIDS,” and Lee “recounted with Frist the history of U.S. efforts to provide global funding,” CQ HealthBeat reports (Adams, 7/25). “‘We have to keep our eyes on the prize,’ and focus on moving forward and figuring out how to work together in a bipartisan way. It happened in the past, [Lee] said, and we can do it again,” “Science Speaks” writes (7/25). Coons “recommended the United States ‘double down’ on investments for AIDS,” in order to “‘innovate and cure our way out of this. That, I think, is in keeping with the optimism and the entrepreneurship of the American character,’ added Mr. Coons,” the Washington Times notes. The discussion was “punctuated by protesters with red umbrellas and signs calling for an end to the ‘criminalization’ of sex workers, drug addicts and other marginalized groups with AIDS,” the Washington Times writes (Wetzstein, 7/25).
World Bank President Jim Yong Kim, in an interview with the Guardian, “said he was passionately committed to ending absolute poverty, which threatens survival and makes progress impossible for the 1.3 billion people living on less than $1.25 a day,” the news service writes. According to the Guardian, Kim “is determined to eradicate global poverty through goals, targets and measuring success in the same way that he masterminded an AIDS drugs campaign for poor people nearly a decade ago,” and he “will set ‘a clear, simple goal’ in the eradication of absolute poverty” (Boseley, 7/25). In a related post in GlobalPost’s “Global Pulse” blog, Kim speaks to correspondent John Donnelly “about the Bank’s focus on eradicating poverty and fighting AIDS.” “Good health is always going to remain a part of a much larger agenda to move people out of poverty,” he says in the interview, adding, “The Bank’s focus has appropriately been on health systems” (7/24).